Grade: A — Strong Financial Health
Framework: Insurance-specific analysis + Schilit principles (traditional manufacturing checks partially N/A for insurers)
Data: Yahoo Finance (10-K filing not cached; analysis based on structured financial data)
Auditor: Information not available from cached filing
One-line verdict: Globe Life is an unusually clean insurance company from an earnings quality perspective — net income of $1.16B, ROE of 19.4%, CFFO/NI ratio of 1.20, and free cash flow of $1.25B covering net income at 1.08x. The company has no goodwill or intangibles concentration issue ($0.5B = 8% of equity), minimal debt ($2.6B) well covered by investment assets ($18.0B), and four consecutive years of steady revenue and earnings growth. Accruals are negligible at -0.8%. The screening engine finds only one watch item (CapEx growth outpacing revenue). For a life insurance company that has faced significant short-seller scrutiny in recent years over its agency practices, the financial statements themselves present a remarkably clean picture. The Beneish M-Score and Altman Z-Score are not applicable to insurance companies, as these models were designed for non-financial firms.
| Metric | Result |
|---|---|
| Red Flags (Engine) | **0** |
| Watch Items | **1** (B2: CapEx growth vs revenue) |
| Checks Completed | **10/18** (8 N/A — standard checks inapplicable to insurers) |
| Beneish M-Score | **N/A** (model does not apply to financial institutions) |
| F-Score (Fraud Probability) | **2.04** (0.76% probability) |
| Altman Z-Score | **N/A** (not applicable to insurance companies) |
| Auditor | Not available from cached data |
| Fiscal Year | 2025 (ended December 31, 2025) |
| Report Date | 2026-04-05 |
Important note on insurance grading: Standard manufacturing-oriented checks like SG&A ratio, gross margin, leverage, and soft asset growth are not meaningful for insurance companies. Insurance earnings quality must be assessed through loss ratios, reserve adequacy, investment portfolio quality, and statutory capital — several of which require the full 10-K text for detailed analysis.
Financial Performance: Steady Growth
| Metric | 2022 | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|---|
| Total Revenue | $5,227M | $5,448M | $5,778M | **$5,994M** | +3.7% |
| Net Income | $894M | $971M | $1,071M | **$1,161M** | +8.4% |
| Net Margin | 17.1% | 17.8% | 18.5% | **19.4%** | Expanding |
| ROE | 22.6% | 21.6% | 20.2% | **19.4%** | Gradually declining |
| CFFO | $1,422M | $1,482M | $1,402M | **$1,396M** | Stable |
| FCF | $1,394M | $1,433M | $1,331M | **$1,254M** | Slight decline |
| CFFO/NI | 1.59 | 1.53 | 1.31 | **1.20** | Declining but healthy |
Revenue has grown consistently for four years from $5.2B to $6.0B. Net income has expanded steadily from $894M to $1.16B. Net margin has improved from 17.1% to 19.4%. ROE remains strong at 19.4%, though declining from the 22.6% peak in 2022 as equity grows.
The CFFO/NI ratio at 1.20 is healthy — insurance companies typically have CFFO exceeding net income because policyholder premiums are collected in advance of claims. The ratio declining from 1.59 to 1.20 over four years is worth monitoring but remains above 1.0.
Balance Sheet: Conservative and Well-Covered
| Item | 2024 | 2025 |
|---|---|---|
| Total Investments/Cash | $17,405M | **$18,049M** |
| Total Debt | $2,740M | **$2,625M** |
| Total Equity | $5,306M | **$5,978M** |
| Goodwill + Intangibles | $475M | **$475M** |
| Goodwill/Equity | 9.0% | **7.9%** |
The balance sheet is conservative: $18.0B in investment assets covers $2.6B in debt nearly 7 times over. Debt actually declined from $2.7B to $2.6B. Goodwill is minimal at $475M (8% of equity), flat year-over-year. Equity grew 13% from $5.3B to $6.0B.
The 18-Point Screening
| # | Check | Result | Detail |
|---|---|---|---|
| A1 | DSO Change | N/A | Insufficient data |
| A2 | AR vs Revenue Growth | N/A | Insufficient data |
| A3 | Revenue vs CFFO | PASS | Revenue +3.7%, CFFO -0.4% |
| B1 | Inventory vs COGS | PASS | No material inventory |
| B2 | CapEx vs Revenue | WATCH | CapEx growth 100.6% vs revenue 3.7% |
| B3 | SG&A Ratio | N/A | Not applicable to insurers |
| B4 | Gross Margin | N/A | Not applicable to insurers |
| C1 | CFFO vs Net Income | PASS | CFFO/NI = 1.20. Cash-backed |
| C2 | Free Cash Flow | PASS | FCF $1.3B, FCF/NI = 1.08 |
| C3 | Accruals Ratio | PASS | -0.8%. Negligible accruals |
| C4 | Cash vs Debt | PASS | Cash $18.0B covers debt $2.6B |
| D1 | Goodwill + Intangibles | PASS | $0.5B = 8% of equity |
| D2 | Leverage | N/A | Not applicable to insurers |
| D3 | Soft Asset Growth | N/A | Not applicable to insurers |
| D4 | Asset Impairment | N/A | No write-off data |
| E1 | Serial Acquirer FCF | PASS | FCF after acquisitions positive |
| E2 | Goodwill Surge | PASS | Goodwill flat YoY |
| F1 | Beneish M-Score | N/A | Not applicable to financial institutions |
Key Risks
1. Short-Seller and Regulatory Scrutiny
Globe Life has faced intense scrutiny from short sellers regarding its agency practices, particularly around its Family Heritage and Liberty National divisions. While the financial statements show clean metrics, this is a governance and compliance risk that sits outside the scope of quantitative screening. Investors should monitor regulatory developments and any DOJ or SEC investigations.
2. CFFO/NI Ratio Trend
The CFFO/NI ratio has declined from 1.59 in 2022 to 1.20 in 2025. While still above 1.0 (meaning earnings are cash-backed), the declining trend could indicate timing shifts in premium collection versus claims payments, or changes in reserve assumptions. If this ratio falls below 1.0, it would be a material warning sign.
3. Insurance Reserve Adequacy
Without the full 10-K text, we cannot assess reserve development patterns (favorable or adverse prior-year development). For a life insurance company, reserve adequacy is the single most important driver of future earnings surprises — both positive and negative.
Key Financial Trends (4-Year)
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $5.2B | $5.4B | $5.8B | $6.0B |
| Net Income | $0.9B | $1.0B | $1.1B | $1.2B |
| Net Margin | 17.1% | 17.8% | 18.5% | 19.4% |
| ROE | 22.6% | 21.6% | 20.2% | 19.4% |
| CFFO/NI | 1.59 | 1.53 | 1.31 | 1.20 |
| FCF | $1.4B | $1.4B | $1.3B | $1.3B |
| Debt | $2.1B | $2.1B | $2.7B | $2.6B |
Summary
Grade: A. Strong financial health. A life insurance company with clean earnings quality metrics but external governance risks to monitor.
Globe Life's financial statements are remarkably clean: zero red flags from the screening engine, CFFO consistently exceeding net income, negligible accruals, minimal goodwill, conservative leverage, and four years of steady growth. The M-Score and Z-Score are not applicable to insurance companies — these models were designed for manufacturing and non-financial firms and produce unreliable results when applied to insurers.
The risks are non-financial-statement in nature:
**Disclaimer**: This report is based on Globe Life's fiscal year 2025 financial data from Yahoo Finance. The full 10-K filing was not available in the local cache. This is NOT investment advice.
**About EarningsGrade**: We screen earnings reports for financial red flags using an 18-point forensic framework. Grade A means the company shows strong financial health.